Patents Examined by Mindy Newman
-
Patent number: 9579358Abstract: Compositions useful for the prevention and/or treatment of Alzheimer's disease are disclosed. The composition comprises carrier particles each linked to a plurality of peptide constructs comprising a peptide binding sequence capable of binding to an amyloid protein and a transit amino acid sequence linked to said binding sequence. The binding sequence may be retroinverted D-peptide mimetic of an L-peptide binding sequence and the transit sequence may be a D-peptide mimetic of an L-peptide transit sequence (e.g. TAT) The preferred peptide construct comprises the sequence rGffvlkGrrrrqrrkkrGy. The preferred carrier particles are liposomes.Type: GrantFiled: October 10, 2012Date of Patent: February 28, 2017Assignee: LANCASTER UNIVERSITY BUSINESS ENTERPRISES LIMITEDInventors: Mark Neville Taylor, David Allsop
-
Patent number: 9486003Abstract: Nutritional compositions having reduced amounts of calories and high amounts of protein and methods of making and using the nutritional compositions are provided. The nutritional compositions may include a processed whole food component, a high amount of protein, and a reduced amount of calories in order to provide a patient with a pH-balanced formulation that includes the benefits of food bioactives beyond essential macro- and micronutrients without providing excessive energy. Methods of administering such nutritional compositions to patients in need of improved bone, muscle, neurological, immune, and/or overall health are also provided.Type: GrantFiled: June 28, 2011Date of Patent: November 8, 2016Assignee: Nestec S.A.Inventors: Doug Bolster, Zamzam Fariba Roughead, Norman Alan Greenberg, Jennifer Mager
-
Patent number: 9446090Abstract: Compositions comprising a mixture of an antimicrobial cationic polypeptide and a second pharmaceutically-acceptable polymer are disclosed, as well as methods and uses thereof for the treatment and prevention of infections that occur when our natural barriers of defense are broken.Type: GrantFiled: March 15, 2013Date of Patent: September 20, 2016Assignee: AMICROBE, INC.Inventors: Michael P. Bevilacqua, Diego Benitez, Jarrod A. Hanson
-
Patent number: 9447148Abstract: Melanocortin receptor-specific cyclic peptides of the formula where R1, R2, R3, R4, R5, R6, R7, R8 and R9 are as defined in the specification, compositions and formulations including the peptides of the foregoing formula or salts thereof, and methods of preventing, ameliorating or treating melanocortin-1 receptor-mediated or responsive diseases, indications, conditions and syndromes.Type: GrantFiled: October 15, 2014Date of Patent: September 20, 2016Assignee: Palatin Technologies, Inc.Inventors: Wei Yang, Yi-Qun Shi
-
Patent number: 9358308Abstract: This invention describes a protein nanoparticle system for targeting siRNA or other drugs into tumors. The basis of the protein system is elastin-like peptides that self-assemble once exposed to the nucleic acid of the siRNA. Specific targeting peptides are fused to the core ELP structure by standard genetic engineering techniques. These targeting peptides confer specific binding of the nanoparticle to receptors on the surface of tumor cells and allow for uptake of the nanoparticle into the tumor cells.Type: GrantFiled: February 7, 2014Date of Patent: June 7, 2016Assignee: NanoOncology, Inc.Inventors: Thomas Primiano, Bey-Dih Chang, Jeremy Heidel
-
Patent number: 9359282Abstract: The present application relates to functionalized nanodiamonds, to complexes comprising a functionalized nanodiamond reversibly bound to a nucleic acid and to compositions comprising such functionalized nanodiamonds and complexes. In particular, the functionalized nanodiamonds comprise at least one naturally occurring basic amino acid, or analogs or derivatives thereof, covalently linked to a nanodiamond. The present application also includes methods and uses of the complexes and compositions, for example for delivering a nucleic acid to a cell.Type: GrantFiled: April 17, 2014Date of Patent: June 7, 2016Assignee: University of SaskatchewanInventors: Ildiko Badea, Ronald Verrall, Jackson M. Chitanda, Randeep Kaur, Saniya Alwani
-
Patent number: 9320773Abstract: The invention is concerned with methods, compounds and pharmaceutical compositions for interfering dendritic cell immunoreceptor (DCIR) activity and signalling events. Described herein are compounds useful in targeting one or more of intracellular modulators and the uses thereof for the prevention or treatment of virus infections, and more particularly for reducing human immunodeficiency virus (HIV) binding, entry and/or replication in human cells. Exemplary compounds include peptides and antisense molecules.Type: GrantFiled: August 4, 2011Date of Patent: April 26, 2016Assignee: Université LavalInventors: Caroline Gilbert, Alexandra Lambert, Michel J. Tremblay
-
Patent number: 9314500Abstract: Methods for the expression and purification of non-N-glycosylated human Annexin A2 in yeast, e.g., in Pichia pastoris, purified Annexin A2 produced by those methods, and methods of using the Annexin A2.Type: GrantFiled: October 11, 2012Date of Patent: April 19, 2016Assignee: The General Hospital CorporationInventor: Zhirui Wang
-
Patent number: 9314514Abstract: The present invention is concerned with modified neurotoxins. Specifically, it relates to a modified biologically active neurotoxin polypeptide comprising at least one poly-Glycine domain. Also contemplated is a polynucleotide encoding the modified neurotoxin polypeptide having a poly-Glycine domain fused to the N-terminus, to the C-terminus or to both of the heavy and/or light chain of the mature neurotoxin polypeptide, vector comprising it and a host cell comprising such a polynucleotide or a vector. Moreover, envisaged are the aforementioned compounds for use as a medicament for treating various diseases.Type: GrantFiled: November 8, 2012Date of Patent: April 19, 2016Assignee: MERZ PHARMA GmbH & CO. KGaAInventor: Karl-Heinz Eisele
-
Patent number: 9301966Abstract: The present disclosure relates to nutritional composition(s) comprising a carbohydrate source, a protein source, a fat source and magnesium threonate. Magnesium threonate may provide neurological health benefits when consumed. The disclosure further relates to methods of promoting neurological health by providing a nutritional composition comprising magnesium threonate. Additionally, the disclosure relates to methods of promoting GI tolerance in a pediatric subject by providing a nutritional composition comprising magnesium threonate.Type: GrantFiled: January 11, 2013Date of Patent: April 5, 2016Assignee: Mead Johnson Nutrition CompanyInventor: Brian Berg
-
Patent number: 9295712Abstract: A flowable or spoonable medicament, food, food ingredient or food supplement is useful for inducing satiety. It comprises a protein and a methylcellulose (MC), wherein the weight ratio w(protein)/w(MC) is at least 0.7/1.0 and the methylcellulose has anhydroglucose units joined by 1-4 linkages wherein hydroxy groups of anhydroglucose units are substituted with methyl groups such that s23/s26 is 0.36 or less, wherein s23 is the molar fraction of anhydroglucose units wherein only the two hydroxy groups in the 2- and 3-positions of the anhydroglucose unit are substituted with methyl groups and wherein s26 is the molar fraction of anhydroglucose units wherein only the two hydroxy groups in the 2- and 6-positions of the anhydroglucose unit are substituted with methyl groups.Type: GrantFiled: October 11, 2012Date of Patent: March 29, 2016Inventors: Britta Huebner-Keese, Matthias Knarr, Roland Adden, Robert L. Sammler, Anne Adden
-
Patent number: 9282758Abstract: Nutritional compositions that mimic whole foods and methods of using the nutritional compositions are provided. The nutritional compositions may include an increased number and variety of fruits and vegetables, an increased variety of macronutrient sources and an increased amount of other components that are found in whole foods. The nutritional compositions may also include ethnicity-specific meals and organic ingredients and provide emotional appeal to the patient and/or the patient's caregiver. Methods of administering such nutritional compositions to patients in need of same are also provided.Type: GrantFiled: June 28, 2011Date of Patent: March 15, 2016Assignee: Nestec S.A.Inventors: Jennifer Mager, Zamzam Fariba Roughead, Heidi Storm, James Scott Teresi
-
Patent number: 9279021Abstract: The present invention relates to fluorescent proteins, in particular green fluorescent proteins (GFPs), with increased activity in cells, and thus increased signal strength. A further aspect of the present invention relates to the use of peptides for increasing the expression and/or stability of a protein in a cell.Type: GrantFiled: June 13, 2014Date of Patent: March 8, 2016Assignee: King Faisal Specialist Hospital & Research CentreInventor: Khalid S. Abu Khabar
-
Patent number: 9273151Abstract: The low-molecular-weight compound represented by the general formula (1): ArX-(Linker)-ArYHB (1), wherein ArX is a structure containing an optionally substituted aromatic six-membered ring, ArYHB is a structure containing an optionally substituted aromatic six-membered ring having a proton donor, the atom group “Linker” has not less than 4 and not more than 30 atoms and binds ArX with ArYHB, is used for binding a proteinaceous substance.Type: GrantFiled: March 23, 2012Date of Patent: March 1, 2016Assignee: Kaneka CorporationInventors: Dai Murata, Shinichi Yoshida
-
Patent number: 9255132Abstract: Provided are angiopoietin-derived peptides or homologs or derivatives thereof, pharmaceutical composition including them, a use thereof for therapy and for the manufacture of a medicament, a method of treating a wide range of conditions, disorders and diseases therewith, nucleotide sequences encoding them, antibodies directed to epitopes thereof and fusion proteins including them.Type: GrantFiled: June 18, 2013Date of Patent: February 9, 2016Assignee: Compugen Ltd.Inventors: Yossef Kliger, Itamar Borukhov, Ofer Levy, Zohar Tiran, Assaf Wool, Ehud Schreiber, Anat Amir, Zurit Levine, Amir Toporik
-
Patent number: 9248159Abstract: The present invention is directed to an enhanced wound healing composition, including a gel containing vancomycin, useful for the prevention of the spread of resistant-type bacteria. Preferably, the drug is one or more antibiotic agents in therapeutically effective concentrations to reduce or eliminate MRSA. The composition is based on a gel composition containing one or more gel forming compounds, such as one or more polymers, preservatives, and/or pH stabilizers and buffers, which not only maintains a moist wound environment to enhance wound healing, but also provides an antibiotic agent which has sustained potency and stability. The composition, when placed in contact with a treatment site, delivers the drug to the site. By incorporating the drug into the gel composition that is formulated to enhance wound healing, the treatment of such disease is possible in a manner which promotes wound healing while reducing or eliminating the MRSA microbe.Type: GrantFiled: November 17, 2011Date of Patent: February 2, 2016Inventor: Robert Stanley Berman
-
Patent number: 9233090Abstract: The present invention relates to the field of nutrition; in particular to the prevention and/or treatment of malnutrition. One embodiment of the present invention relates to a nutritional composition enriched in cysteine for use in the treatment and/or prevention of malnutrition and disorders related thereto. Such a composition may in particular, but not exclusively, be useful for the elderly population.Type: GrantFiled: October 19, 2011Date of Patent: January 12, 2016Assignee: Nestec S.A.Inventors: Denis Breuille, Isabelle Papet, Karine Vidal
-
Patent number: 9200082Abstract: Embodiments of the invention are directed to fibrillar adjuvants. For example, epitopes assembled by a synthetic peptide domain into nanofibers comprising a ?-fibrillization peptide may elicit high antibody titers in the absence of any adjuvant. In certain embodiments, multiple different antigens may be integrated into polypeptide nanofibers, providing biomaterials with modular and precise composition of bioactive proteins.Type: GrantFiled: March 13, 2014Date of Patent: December 1, 2015Assignee: The University of ChicagoInventors: Joel Collier, Gregory Hudalla
-
Patent number: 9193779Abstract: The present invention discloses protein fragment including a cell binding region of fibronectin and methods of using the same for cell culture. Additionally, surfaces modified with such protein fragment and compositions including the same are provided. Desirably, such surfaces allow various cells to adhere thereto yet avoid issues associated with animal-derived products.Type: GrantFiled: March 15, 2013Date of Patent: November 24, 2015Assignee: Corning IncorporatedInventors: Deepa Saxena, Himabindu Nandivada
-
Patent number: 9192624Abstract: The present invention aims to provide a medical material which is safe for the live body, has high biocompatibility and is useful for promotion of cell differentiation. The present invention produces a medical material for promoting cell differentiation, which contains polyamino acid as a main component, wherein the polyamino acid contains at least one kind of amino acid residue selected from the group consisting of an alanine residue, a valine residue, a leucine residue, an isoleucine residue, a phenylalanine residue, a glycine residue, a glutamine residue, an aspartic acid residue optionally containing a protecting group in the side chain, a tyrosine residue optionally containing a protecting group in the side chain, a tryptophan residue optionally containing a protecting group in the side chain, a lysine residue optionally containing a protecting group in the side chain, and a glutamic acid residue optionally containing a protecting group in the side chain.Type: GrantFiled: June 6, 2013Date of Patent: November 24, 2015Assignee: AJINOMOTO CO., INC.Inventors: Manabu Kitazawa, Satoru Ohashi, Yoko Masuzawa, Kousaku Ohkawa, Yasuhiko Tabata